RxDoctor Payments Data

Deshala Frazier, APRN

Family · Madison, FLNPI 1356886196

Payments from drug & device makers

$558in general payments, 2019–2025

Across 33 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$198
  • AstraZeneca$87
  • Bayer$80
  • Lilly USA, LLC$45
  • GSK$29
  • Pfizer$19
  • plus $101 from 6 others

What the payments were for

  • Food & beverage$558100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$558 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$170
Medicare patients
15
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$20,282
OzempicSemaglutide12$20,225
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$19,462
MounjaroTirzepatide13$13,541
FarxigaDapagliflozin Propanediol17$11,025
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,758
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,454
Omega-3 Acid Ethyl Esters13$1,181
Albuterol Sulfate HfaAlbuterol Sulfate30$1,098
Gabapentin42$837
Omeprazole43$708
Rosuvastatin Calcium49$654
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst30$566
Celecoxib11$516
Fluticasone Propionate24$504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$87$20,78328 claims
PfizerEliquis$19$20,28220 claims
Novo NordiskOzempic$198$20,22512 claims
GSKTrelegy Ellipta$29$19,46227 claims
Lilly USA, LLCMounjaro$45$13,54113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Madison

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →